The HIV Medication Access Act amends the Foreign Assistance Act of 1961 to expand U.S. international HIV/AIDS programs by designating HIV prevention and treatment activities as "core life-saving humanitarian assistance." The bill specifically adds HIV pre-exposure prophylaxis (PrEP) medications to the list of assistance activities that the U.S. can provide to combat HIV/AIDS abroad, and directs these efforts to focus on at-risk populations using scientific guidance from the World Health Organization. By classifying these activities as core humanitarian assistance, the legislation aims to prioritize and protect funding for HIV prevention and medication access in U.S. foreign aid programs. The bill does not specify a particular dollar amount or implementation timeline, but it effectively strengthens the legal framework for sustained international HIV prevention and treatment support.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.